Home » Recalls Drain $900 Million From J&J’s Pocket in 2010
Recalls Drain $900 Million From J&J’s Pocket in 2010
Johnson & Johnson’s (J&J) string of consumer product recalls cost the company $900 million in sales last year, and more recalls are possible as the company begins scrutinizing external manufacturers.
J&J subsidiary McNeil Consumer Healthcare’s OTC product recalls, coupled with the suspension of production at its Fort Washington, Pa., plant, cost the company about $300 million in fourth quarter sales and about $900 million in total year sales, Louise Mehrotra, vice president of investor relations, said during a conference call last month.
Net earnings were $1.9 billion for the quarter compared to $2.2 billion for the same period in 2009. McNeil identified the issues during a product quality and process assessment, and it has now completed its assessment of historical records, as far back as 2007, for products sold in the U.S.
Drug GMP Report
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May